Automated Characterization of Biotherapeutics via Hardware, Software and Chemistry
In this episode, we welcome Dr Harsha Gunawardena, principal scientist at Jansen Research and Development, Johnson & Johnson.
Harsha discusses bi & multispecific antibodies including the challenges that manufacturers face when developing novel therapeutics. He reveals how scientists at Janssen are working to deliver better analytical methods and advanced data processing tools to help them streamline biotherapeutic development workflows.
Further Reading:
Harsha discusses bi & multispecific antibodies including the challenges that manufacturers face when developing novel therapeutics. He reveals how scientists at Janssen are working to deliver better analytical methods and advanced data processing tools to help them streamline biotherapeutic development workflows.
Further Reading:
Interested in seeing more content from Protein Metrics?
Discover all their latest news, webinars, products and more by clicking the link below.